Hepatitis virus and kidney

Singapore Medical Journal

Volumn 37, Issue 6, 1996, Pages 639-644

  Praditpornsilpa, K ^b   Eiam Ong, S ^a   Sitprija, V ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b POLICE GENERAL HOSPITAL   (Thailand)

Author keywords

glomerulonephritis; hepatitis A; hepatitis B; hepatitis C; post renal transplantation; renal failure

Indexed keywords

INTERFERON;

ARTICLE; DISEASE COURSE; GLOMERULONEPHRITIS; GLOMERULOPATHY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PATHOGENESIS; SYMPTOMATOLOGY; VIRUS HEPATITIS;

EID: 0030425674     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Rao KV, Anderson WR. Liver disease after renal transplantation. Am J Kidney Dis 1994; 8: 496-501.
2. Gocke D. Hepatitis A revisited. Ann Intern Med 1986; 105: 960-1.
3. Eng C, Chopra S. Acute renal failure in nonfulminant hepatitis A. J Clin Gastroenterol 1990; 12: 717-20.
4. Matloo TK, Mahmood MA, al-Sowailem AM. Acute renal failure in nonfulminant hepatitis A infection. Ann Trop Ped 1991; 11: 213-6.
5. Schmidli RS, Lynn KL. Acute renal failure complicating nonfulminating hepatitis A infection a case report. New Zealand Med J 1990; 103: 375-7.
6. Agrawal RK, Moudgil A, Kishore K. Acute viral hepatitis, intravascular hemolysis, severe hyperbilirubinemia and renal failure in glucose 6 phosphate dehydrogenase deficiency patients. Postgrad Med J 1985; 61: 971-3.
7. Heidenberg D, Dally D. Inapparent infection with hepatitis A virus and glomerulonephritis in a child. Harefuah 1992; 122: 164-5.
8. Miller RH, Kareko S, Chung CT, Girones R, Purcell RH. Compact organization of the hepatitis virus genome. Hepatology 1989; 9: 322-7.
9. Beasley RP, Hwang LY, Lin CC, Lue ML, Stevens CE, Szumuness W, Chen KP. Incidence of hepatitis B virus infection in meschool children in Taiwan. J infect Dist 1982; 146: 198-204.
10. Combes B, Stastny P, Shorey J, Eigenbrodt EH, Barrera A, Hull AR, Carter NW. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971; 2: 234-7.
11. Takeoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S. Strong association between membranous nephropathy and hepatitis B surface antigenemia in Japanese children. Lancet 1978; 2: 1065-8.
12. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, vallance-Owen J. The clinico-pathological features of hepatitis B virus associated glomerulonephritis. Q J Med 1987; 63: 323-33.
13. Lai KN, Li PKT, Lui SF, Au TC, Tam JSL, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adult. N Engl J Med 1991; 324: 1457-62.
14. Monthon L, Deblois P, Sauvaget F, Meyrier A, Callard P, Guillevin L. Hepatitis B virus related polyateritisnodosa and membranous nephropathy. Am J Nephrol 1995; 15: 266-9.
15. 2 fragments of monoclonal antibody. Kidney Int 1984; 26: 338-41.
16. Lin CY. Hepatitis B virus deoxyribonucleic acid in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nephropathy patient. Nephron 1993; 63: 58-64.
17. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse. Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr 1979; 95: 946-52.
18. Seggie J, Nathoo K, Davies PG. Association of hepatitis B antigenaemia and membranous glomerulonephritis in Zimbabwean children. Nephron 1984; 38: 115-9.
19. Brzosko WJ, Krawczynski K, Nazarewiez T, Morzyeka M, Nowoslawski A. Glomerulonephritis associated with hepatitis B surface antigen immune complexes in children. Lancet 1974; 2: 476-82.
20. Lai KN, Tam JS, Hsiang JL, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990; 54: 12-7.
21. Hoofnagle JH, Peter M, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, et al. Randomized controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-25.
22. Perrillo RP, Schiff ER, Davis GL, Bodenheimer Jr HC, Lindsay K, Payne J, et al. The Hepatitis Interventional Therapy Group. A randomized controlled trial of interferon alfa 2 b alone and after prednisolone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
23. Alexander GM, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston ALWF, et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 2: 66-8.
24. Mizushima M, Kanal K, Matsuda H, Matsumoto M, Tamakoshi K, Ishii H, et al. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 1987; 92: 524-6.
25. Lisker-Melman M, Webb D, Di Bisceglie, Kassianides C, Martin P, Rustgi V, et al. Glomenilonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med 1989; 111: 479-83.
26. Lok ASF, Lai CL, Wu PC, Leung EKY Long term follow up in a randomized controlled trial of recombinant 2-interferon in Chinese patients with chronic hepatitis infection. Lancet 1988;2: 298-302.
27. Druwe PM, Michielsen PP, Ramon AM, De Bore ME. Hepatitis C and nephrology. Nephrol Dial Transplant 1994; 9: 230-7.
28. Roth D. Hepatitis C Virus: The Nephrologist's view. Am J Kidney Dis 1995, 25: 3-16.
29. van der Poel Cl, Cuypers HTM, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475-9.
30. van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, De Nello R, et al. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet 1991; 337: 317-9.
31. van der Poel CL, Cuypers HTM, Reesink HW, Choo QL, Kuo G, Han J, et al. Risk factors in HCV infected blood donors Transfusion 1991; 31: 777-9.
32. Ohto H, Terazawa S, Sasaki N, Hino K, Ishwiwata C, Kako M, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-50.
33. Bresters D, Mauser-Bunschoten EP, Reesink HW, Roosendaal G, van der Poel CL, Chamuleau RAFM, et al. Sexual transmission of hepatitis C virus. Lancet 1993; 342: 210-1.
34. Calabrese G, Vagelli G, Guaschino R, Gonella M. Transmission of anti HCV within the household of haemodialysis patient (letter). Lancet 1991; 338; 1466-7.
35. Ware AJ, Luby JP, Hollinger B, Eigenbrodt EH, Cuthbert JA, Atkins CR, et al. Etiology of liver disease in renal transplant patients. Ann Intern Med 1979; 91: 364-71.
36. Oliveras A, Lioveras J, Puig JM, Comerma I, Bruguera M, Barrera J, et al. Hepatitis C virus in renal transplantation. Transplant Proc 1991; 23: 2636-7.
37. Rao KV, Anderson RC, O'Brien TJ. Morphology and natural history of chronic liver disease in renal allograft recipients. Transplant Proc 1985; 17: 165-7.
38. Rao KV, Anderson WR, Kasiske BL, Dahl DC. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241-50.
39. Fist MR. Diagnosis and management of long-term complications of transplantation. In current clinical practice in nephrology, dialysis, and transplantation. Continuing Medical Education Program XIIIth International Congress of Nephrology July 2-6, 1995, Madrid, Spain: ISN Press: 72-6.
40. nd international course, Lyon, 3-5 June 1991. Experta medica, 1991: 81-6.
41. Hirsch M, Tolko H-Rubin N, Kelly A, Rubin R. Pharmacokinetics of human and recombinant leukocyte interferon in patient with chronic renal failure who are undergoing hemodialysis. J Infect Dis 1983; 148: 335-40.
42. Diethelm AG, Roth D, Ferguson RM. Transmission of HCV by Organ transplantation (letter). N Engl J Med 1992; 326: 410-1.
43. Mizrahi S, Hussey JL, Hayes DH, Boudreanx JP. Organ transplantation and hepatitis C virus infection (letter). Lancet 1991; 337: 1100.
44. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C. Non transmission of hepatitis C from cadaveric kidney donors to transplant recipient. Transplantation 1993; 55: 674-5.
45. Mendez R, Aswad S, Bogaard U, Khetan U, Asai P, Martinez A. Donor hepatitis C antibody virus testing in renal transplantation. Transplant Proc 1993; 25: 1487-90.
46. Schweitzer E, Barlett S, Keay S, Hadley G, Cregar J, Stockdreher D. Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States. Transplant Proc 1993; 25: 1456-7.
47. Appel GB. Immune-complex glomerulonephritis-Deposits plus interest. N Engl J Med 1993; 328: 505-6.
48. Johnson RJ, Wilson R, Yamabe H, Couser W, Alpers CE, Wener MH, et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994; 46: 1255-63.
49. Rollino C, Roccatello D, Grachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991; 59: 319-20.
50. Johnson RJ, E Alpers C, Stehman-Breen C, Wilson R, Couser WG. Pathogenesis of hepatitis C virus associated glomerulonephritis. Nephrology 1995; 1: 11-6.
51. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7.
52. Pawlotsky JM, Yahia MB, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis. A prospective case control study. Hepatol 1994; 19: 841-8.
53. Yamabe H, Johnson RJ, Gretch DR, Osawa H, Inuma H, Sasaki T, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-α. Am J Kidney Dis 1995; 25: 67-9.